Promotional price valid on web orders only. Your contract pricing may differ. Interested in signing up for a dedicated account number?
Learn More

Medchemexpress LLC Migoprotafib (GDC-1971) | 2377352-49-1 | 98.8% | C25H26N8O | 10MG
SDP

Catalog No. 5000258370
Encompass_Preferred

Migoprotafib (GDC-1971) is a small-molecule SHP2 inhibitor used in preclinical research to inhibit the MAPK/ERK signaling pathway and evaluate antitumor activity. It is supplied as a light yellow solid with high reported purity and is available in multiple solid pack sizes and as a DMSO solution suitable for biochemical and cell-based assays.

  • SHP2 inhibitor that modulates the MAPK/ERK signaling pathway.
  • High reported purity, 98.8%.
  • Light yellow to yellow solid appearance.
  • Available as multiple solid pack sizes and as a 10 mM DMSO solution for assays.
  • Molecular formula C25H26N8O; molecular weight 454.53 g·mol⁻¹.
  • SMILES provided for cheminformatics applications.

Catalog No. 50-002-58370 Supplier Medchemexpress LLC Supplier No. HY14490310MG
May include imposed supplier surcharges.
Add to Cart
Add to Cart

Migoprotafib (GDC-1971) is a small-molecule SHP2 inhibitor used in preclinical research to inhibit the MAPK/ERK signaling pathway and evaluate antitumor activity. It is supplied as a light yellow solid with high reported purity and is available in multiple solid pack sizes and as a DMSO solution suitable for biochemical and cell-based assays.

  • SHP2 inhibitor that modulates the MAPK/ERK signaling pathway.
  • High reported purity, 98.8%.
  • Light yellow to yellow solid appearance.
  • Available as multiple solid pack sizes and as a 10 mM DMSO solution for assays.
  • Molecular formula C25H26N8O; molecular weight 454.53 g·mol⁻¹.
  • SMILES provided for cheminformatics applications.

Product Title
Select an issue

By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.